Literature DB >> 18992653

Nonsteroidal anti-inflammatory drugs and cardiovascular risk: is prostacyclin inhibition the key event?

Pietro Minuz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18992653     DOI： 10.1016/j.jacc.2008.08.042

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  4 in total

1.  Methods in clinical pharmacology.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

2.  Distinct role of Kruppel-like factor 11 in the regulation of prostaglandin E2 biosynthesis.

Authors:  Navtej S Buttar; Cathrine J DeMars; Gwen Lomberk; Sumera Rizvi; Juliana Bonilla-Velez; Shalini Achra; Shahrooz Rashtak; Kenneth K Wang; Martin E Fernandez-Zapico; Raul Urrutia
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

3.  Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity.

Authors:  Y Ikeda-Matsuo; Y Hirayama; A Ota; S Uematsu; S Akira; Y Sasaki
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

4.  Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.

Authors:  Anne-Marie Schjerning Olsen; Emil L Fosbøl; Jesper Lindhardsen; Charlotte Andersson; Fredrik Folke; Mia B Nielsen; Lars Køber; Peter R Hansen; Christian Torp-Pedersen; Gunnar H Gislason
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.